Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery

Journal of Orthopaedics and Traumatology

Volumn 12, Issue 1, 2011, Pages 69-76

  Randelli, F ^a   Biggi, F ^b   Della Rocca, G ^c   Grossi, P ^a   Imberti, D ^d   Landolfi, R ^e   Palareti, G ^f   Prisco, D ^g,h  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b Hospital of Belluno   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^e FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

^h CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Anticoagulant prophylaxis; Dabigatran; Enoxaparin; Femoral neck fractures; Prevention of venous thromboembolism; Rivaroxaban; Total hip replacement; Total knee replacement

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; DABIGATRAN; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN;

ARTICLE; CLINICAL PRACTICE; COMPRESSION GARMENT; COMPRESSION THERAPY; CONSENSUS DEVELOPMENT; FEMUR NECK FRACTURE; HIP ARTHROPLASTY; HUMAN; ITALY; KNEE ARTHROPLASTY; PATIENT CARE PLANNING; PATIENT IDENTIFICATION; PATIENT SAFETY; PRIORITY JOURNAL; REGIONAL ANESTHESIA; RISK ASSESSMENT; THROMBOSIS PREVENTION; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CONSENSUS; FEMORAL NECK FRACTURES; FIBRINOLYTIC AGENTS; HUMANS; ITALY; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; THROMBOSIS;

EID: 79952814299     PISSN: 15909921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10195-010-0125-8     Document Type: Article

References (30)

1. WH Geerts D Bergqvist GF Pineo JA Heit CM Samama MR Lassen CW Colwell 2008 American College of Chest Physicians. Prevention of venous thromboembolism American College of Chest Physicians evidence-based clinical practice guidelines (8th edn) Chest 133 Suppl 381S 453S 18574271 10.1378/chest.08-0656 1:CAS:528:DC%2BD1cXptVKhsrg%3D (Pubitemid 351894916)
2. Prisco D, Violi F (2002) Linee guida per la profilassi del tromboembolismo venoso in chirurgia ortopedica maggiore: cosa pensa la Società Italiana per lo Studio dell'Emostasi e della Trombosi. Haematologica 87 (Suppl 4):11-13
3. Prisco D, Gruppo di lavoro per le linee guida sul tromboembolismo venoso della Società Italiana per lo Studio dell'Emostasi e della Trombosi (coordinatore Prisco D) (2003) Linee guida per la diagnosi, la profilassi e la terapia del tromboembolismo venoso. Haematologica 88 (Suppl 18):1-61
4. Prevention and treatment of venous thromboembolism 2006 International consensus statement Int Angiol 25 1001 1161
5. Hill J (2010) Treasure T; National Clinical Guideline Centre for acute and chronic conditions. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ 340:c95
6. N Strebel M Prins G Agnelli HR Büller 2002 Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecularweight heparin in elective hip surgery? Arch Intern Med 162 1451 1456 12090880 10.1001/archinte.162.13.1451 1:CAS:528:DC%2BD38XlslOit7k%3D (Pubitemid 34747477)
7. GE Raskob J Hirsh 2003 Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery Chest 124 379S 385S 14668421 10.1378/chest.124.6-suppl.379S (Pubitemid 38005465)
8. AG Turpie KA Bauer BI Eriksson MR Lassen 2002 Fondaparinux versus enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery Arch Intern Med 162 1833 1840 12196081 10.1001/archinte.162.16.1833 1:CAS:528:DC%2BD2MXktFOnsbY%3D
9. CW Colwell Jr LM Kwong AG Turpie BL Davidson 2006 Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery J Arthroplasty 21 36 45 16446183 10.1016/j.arth.2005.05.023 (Pubitemid 43162983)
10. Gogarten W, Vandermeulen E, Van Aken H, Kozek S, Llau JV, Samama CM (2010) Regional anaesthesia and antithrombotic agents: recommendations of the European society of Anaesthesiology. Eur J Anaesthesiol 27(12):999-1015
11. BI Eriksson OE Dahl N Rosencher AA Kurth CN van Dijk SP Frostick MH Prins R Hettiarachchi S Hantel J Schnee Büller HR; RE-NOVATE Study Group 2007 Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: randomized, double-blind, noninferiority trial Lancet 370 949 956 17869635 10.1016/S0140-6736(07)61445-7 1:CAS:528: DC%2BD2sXhtVeqsL7F (Pubitemid 47393577)
12. BI Eriksson OE Dahl N Rosencher AA Kurth CN van Dijk SP Frostick P Kälebo AV Christiansen S Hantel R Hettiarachchi J Schnee Büller HR; RE-MODEL Study Group 2007 Oral dabigatran etexilate versus subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement. The RE-MODEL randomized trial J Thromb Haemost 5 2178 2185 17764540 10.1111/j.1538-7836.2007.02748.x 1:CAS:528:DC%2BD2sXhsVSis7fM (Pubitemid 47617868)
13. BI Eriksson LC Borris RJ Friedman S Haas MV Huisman AK Kakkar TJ Bandel H Beckmann E Muehlhofer F Misselwitz W Geerts RECORD1 Study Group 2008 Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty N Engl J Med 358 2765 2775 18579811 10.1056/NEJMoa0800374 1:CAS:528: DC%2BD1cXnvFahtbo%3D (Pubitemid 351930851)
14. AK Kakkar B Brenner OE Dahl BI Eriksson P Mouret J Muntz AG Soglian AF Pap F Misselwitz S Haas RECORD2 Investigators 2008 Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial Lancet 372 31 39 18582928 10.1016/S0140-6736(08)60880-6 1:CAS:528:DC%2BD1cXotlWqsrg%3D
15. MR Lassen W Ageno LC Borris JR Lieberman N Rosencher TJ Bandel F Misselwitz AG Turpie RECORD3 Investigators 2008 Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty N Engl J Med 358 2776 2786 18579812 10.1056/NEJMoa076016 1:CAS:528:DC%2BD1cXnvFagt70%3D (Pubitemid 351930852)
16. AG Turpie MR Lassen BL Davidson KA Bauer M Gent LM Kwong FD Cushner PA Lotke SD Berkowitz TJ Bandel A Benson F Misselwitz WD Fisher RECORD4 Investigators 2009 Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Lancet 373 1673 1680 19411100 10.1016/S0140-6736(09)60734-0 1:CAS:528:DC%2BD1MXmtVWjtL4%3D
17. LA Hooker PF Lachiewicz SS Kelley 1999 Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty J Bone Joint Surg Am 81 690 696 10360697 1:STN:280:DyaK1M3oslCnsA%3D%3D (Pubitemid 29241154)
18. JW Eikelboom DJ Quinlan JD Douketis 2001 Extended duration prophylaxis against venous thromboembolism after total hip replacement: a metaanalysis of the randomised trials Lancet 358 9 15 11454370 10.1016/S0140-6736(00)05249-1 1:STN:280:DC%2BD3Mvgt1Gkug%3D%3D (Pubitemid 32709732)
19. TT Horlocker 2001 Low molecular weight heparin and neuraxial anesthesia Thromb Res 101 141 154 10.1016/S0049-3848(00)00386-8
20. TT Horlocker DJ Wedel JC Rowlingson FK Enneking SL Kopp HT Benzon DL Brown JA Heit MF Mulroy RW Rosenquist M Tryba CS Yuan 2010 Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American society of regional Anesthesia and pain medicine evidence-based guidelines (3rd edn) Reg Anesth Pain Med 35 64 101 20052816 10.1097/AAP.0b013e3181c15c70 1:CAS:528:DC%2BC3cXhslWjurg%3D
21. FJ Singelyn CC Verheyen F Piovella HK Van Aken N Rosencher EXPERT Study Investigators 2007 The safety and efficacy of extended prophylaxis with fondaparinux after major orthopaedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT study Anesth Analg 105 1540 1547 18042845 10.1213/01.ane.0000287677.95626.60 1:CAS:528: DC%2BD2sXhtlGgu7zO (Pubitemid 350190541)
22. MR Lassen GE Raskob A Gallus G Pineo D Chen RJ Portman 2009 Apixaban or enoxaparin for thromboprophylaxis after knee replacement N Engl J Med 361 594 604 19657123 10.1056/NEJMoa0810773 1:CAS:528:DC%2BD1MXps1Kitrc%3D
23. MR Lassen GE Raskob A Gallus G Pineo D Chen P Hornick ADVANCE-2 investigators 2010 Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial Lancet 375 807 815 20206776 10.1016/S0140-6736(09)62125-5 1:CAS:528:DC%2BC3cXivFegsrg%3D
24. www.chestnet.org : American College of Chest Physicians
25. www.nice.org.uk : National Institute for Health and Clinical Excellence
26. www.otodi.com : Ortopedici e Traumatologi Ospedalieri D'Italia
27. www.siaarti.it : Società Italiana di Anestesia Analgesia, Rianimazione e Terapia Intensiva
28. www.sign.ac.uk : Scottish Intercollegiate Guidelines Network
29. www.siot.it : Società Italiana di Ortopedia e Traumatologia
30. www.siset.org : Società Italiana per lo Studio dell'Emostasi e della Trombosi